Protein Nanoscale Organization: Unlocking Surfaceomes to Power Next-Generation Therapeutics

2:00 pm - Wednesday 4th February 2026

  • Introducing DISCOtech: DISCO's proprietary surfaceome proteomics platform and workflow to systematically map nanoscale organizations on the cell-surface proteins across tumor types
  • Demonstrating how DISCOtech reveals tumor-specific vulnerabilities inaccessible through traditional genomics or transcriptomics
  • Showcasing the translation from surfaceome discoveries to target candidates into differentiated antibody-based therapeutics with enhanced efficacy and safety profiles

Speakers:

Vice President, Technology
DISCO Pharmaceuticals